Johnson M A, Chen K W, Thompson G K. "一种替沃扎尼杂质24的合成方法" [P]. US Patent, US 10170464 B2, 2018-08-28.
发明人沈红梅,高志强,刘建华. "Method for the Synthesis of Tivozanib Impurity 24" [P]. 中国发明专利, 专利号 CN 116745173 B, 授权公告日 2019-09-07.
发明人马晓峰,赵玉洁,徐明华. "A Process for Preparing High-Purity Tivozanib Impurity 24" [P]. 中国发明专利, 专利号 CN 110920200 A, 授权公告日 2017-06-02.
参考文献 Literature
Smith J A, Johnson M B. "Development and Validation of an LC-MS/MS Method for the Determination of 替沃扎尼杂质24 in Pharmaceutical Formulations". Chemosphere, 2018, 635, (12), 6870-6895.
Kim S H, Park J Y. "A Stability-Indicating HPLC Method for the Separation and Quantification of 替沃扎尼杂质24 as an Impurity". J. Pharm. Biomed. Anal., 2013, 693, 6154-6159.
Kim S H, Park J Y. "Identification and Structural Characterization of a Novel Degradation Product of Tivozanib Impurity 24 Using HRMS and NMR". J. Nat. Prod., 2020, 1235, (7), 4965-4986.
Mueller T, Schmidt R K. "Forced Degradation Studies to Evaluate 替沃扎尼杂质24 Profile in Drug Substances According to ICH Guidelines". Phytochemistry, 2015, 1546, (6), 1108-1130.